Norum J, Wist E
Kreftavdelingen, Regionsykehuset i Tromsø.
Tidsskr Nor Laegeforen. 1992 Apr 10;112(10):1314-6.
Nuclear accidents are a cause of widespread fear. Treatment of patients exposed to high doses of total body irradiation has very often been ineffective. The use of hematopoietic growth factors may be a new way of treating these patients. This article describes results from studies of total body irradiated animals and clinical experience from treating humans who have been involved in nuclear accidents. G-CSF or GM-CSF administered within three hours after a nuclear accident seems to be of value. Surprisingly, so far bone marrow transplantation seems to be of limited value. Intravenous transfusions of thrombocytes and red blood cells, and the treatment of burns and gastrointestinal symptoms, are important parts of the medical therapy.
核事故是引发广泛恐惧的一个原因。对遭受高剂量全身照射的患者进行治疗往往效果不佳。使用造血生长因子可能是治疗这些患者的一种新方法。本文描述了对全身照射动物的研究结果以及治疗核事故相关人类患者的临床经验。在核事故发生后三小时内给予粒细胞集落刺激因子(G-CSF)或粒细胞-巨噬细胞集落刺激因子(GM-CSF)似乎具有价值。令人惊讶的是,到目前为止骨髓移植似乎价值有限。血小板和红细胞的静脉输血以及烧伤和胃肠道症状的治疗是医学治疗的重要组成部分。